Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1628867
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1628867
Bioconjugation Market, By Type, By Technique, By Offering, By Bioconjugation Type, By Application, By Therapeutic Area, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
PUBLISHED:
PAGES: 398 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Bioconjugation market size was valued at USD 5,122.32 Million in 2023, expanding at a CAGR of 15.2% from 2024 to 2032.
Bioconjugation is the process of chemically linking two biomolecules, such as proteins, antibodies, or nucleic acids, to enhance their functionality or specificity. This technique is widely applied in drug development, diagnostics, and imaging. By attaching therapeutic agents or markers to biomolecules, bioconjugation enables targeted delivery, improved stability, and reduced side effects. It is a cornerstone in developing antibody-drug conjugates, biosensors, and personalized medicine, significantly advancing biotherapeutics and biomedical research.
Bioconjugation Market- Market Dynamics
Rising demand for antibody-drug conjugates (ADC) growth to propel market demand
ADCs, a critical application of bioconjugation, are expected to witness strong growth due to their targeted cancer therapies. Besides, expanding applications of biotherapeutics in treating chronic diseases boost bioconjugation research. However, advanced bioconjugation techniques demand significant financial investment, limiting accessibility for smaller firms. On the contrary, novel conjugation tools improve efficiency, encouraging broader applications in diagnostics and personalized medicine. Furthermore, increasing funding supports R&D, creating new avenues for bioconjugation market growth.
Bioconjugation Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.2% over the forecast period (2024-2032)
Based on type segmentation, natural bioconjugations was predicted to show maximum market share in the year 2023
Based on technique segmentation, amide bond formation was the leading type in 2023
Based on offering segmentation, services were the leading type in 2023
Based on bioconjugation type segmentation, protein bioconjugation was the leading type in 2023
Based on application segmentation, therapeutic was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
Bioconjugation Market- Segmentation Analysis:
The Global Bioconjugation Market is segmented on the basis of Type, Technique, Offering, Bioconjugation Type, Application, Therapeutic Area, End User, and Region.
The market is divided into two categories based on Type: synthetic bioconjugates and natural bioconjugates. The natural bioconjugates segment is expected to dominate the bioconjugation market due to its widespread application in biologics and drug development, offering high specificity and compatibility with biological systems.
The market is divided into five categories based on Technique: amide bond formation, click chemistry, bio-orthogonal reactions, and enzymatic methods, and thiol-maleimide coupling. The amide bond formation sector dominates the market and is likely to maintain its dominance during the forecast period. This is due to its extensive use in linking biomolecules for therapeutic and diagnostic applications. Its stability and efficiency make it widely preferred.
Bioconjugation Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Bioconjugation Market- Competitive Landscape:
Driven by the increasing demand for targeted therapies and drug delivery innovations, the bioconjugation market sees strategies like R&D investments for novel technologies, partnerships to expand applications, and product differentiation through advanced conjugation techniques. Companies focus on optimizing linkers and payloads for better efficacy and safety. Additionally, the market emphasizes regulatory compliance and scaling manufacturing capabilities to meet growing demands in biopharmaceuticals and diagnostics. These strategies collectively enhance market competitiveness and enable the development of next-generation therapeutic solutions.
Recent Developments:
In November 2024, Lonza announced that it is expanding its bioconjugation facility in Visp, Switzerland, adding two 1,200 L manufacturing suites and infrastructure, creating 200 jobs. Operations are expected to begin in 2028.
In March 2024, Abzena announced that it is expanding its Bristol, PA bioconjugate manufacturing site with a $5 million investment in new equipment, upgraded facilities, and enhanced laboratory space, boosting biopharmaceutical program capacity.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BIOCONJUGATION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- AbbVie Inc.
- Abcam plc
- Abzena Limited
- Agilent Technologies, Inc.
- AstraZeneca PLC
- Biocon Limited
- Bio-Techne Corporation
- Boehringer Ingelheim GmbH
- Charles River Laboratories International, Inc.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- GlaxoSmithKline plc
- F. Hoffmann-La Roche AG
- Innovagen AB
- Lonza Group AG
- Johnson & Johnson Services Inc.
- Merck KGaA
- Sanofi S.A.
- Pfizer Inc.
- Sartorius AG
- Sutro Biopharma, Inc.
- Sorrento Therapeutics, Inc.
- Thermo Fisher Scientific Inc.
- WuXi AppTec Co., Ltd.
- Others
GLOBAL BIOCONJUGATION MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Natural Bioconjugates
- Synthetic Bioconjugates
GLOBAL BIOCONJUGATION MARKET, BY TECHNIQUE- MARKET ANALYSIS, 2019 - 2032
- Amide Bond Formation
- Click Chemistry
- Bio-orthogonal Reactions
- Thiol-Maleimide Coupling
- Enzymatic Methods
GLOBAL BIOCONJUGATION MARKET, BY OFFERING- MARKET ANALYSIS, 2019 - 2032
- Reagents & Kits
- Services
- ADC Process Development
- Drug Substance Manufacturing
- Analytical Development
- Early Development Bioconjugate Services
- Targeting Agent or Carrier Protein Services
- Payload & Linker Manufacturing
GLOBAL BIOCONJUGATION MARKET, BY BIOCONJUGATION TYPE- MARKET ANALYSIS, 2019 - 2032
- Oligonucleotide Bioconjugation
- Single-stranded Oligonucleotides
- Double-stranded Oligonucleotides
- Polymer Bioconjugation
- Peptide Bioconjugation
- Protein Bioconjugation
GLOBAL BIOCONJUGATION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Diagnostics
- Therapeutic
- Vaccines
- Monoclonal Antibodies
- Antibiotics
- Research & Development
GLOBAL BIOCONJUGATION MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032
- Infectious Diseases
- Immunology
- Cardiovascular Disorders
- Oncology
GLOBAL BIOCONJUGATION MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Biotechnology Companies
- Academic & Research Institutions
- Pharmaceutical Companies
- Contract Research Organizations
GLOBAL BIOCONJUGATION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV4390
Table of Contents
1. Bioconjugation Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Bioconjugation Market Snippet by Type
- 2.1.2. Bioconjugation Market Snippet by Technique
- 2.1.3. Bioconjugation Market Snippet by Offering
- 2.1.4. Bioconjugation Market Snippet by Bioconjugation Type
- 2.1.5. Bioconjugation Market Snippet by Application
- 2.1.6. Bioconjugation Market Snippet by Therapeutic Area
- 2.1.7. Bioconjugation Market Snippet by End User
- 2.1.8. Bioconjugation Market Snippet by Country
- 2.1.9. Bioconjugation Market Snippet by Region
- 2.2. Competitive Insights
3. Bioconjugation Key Market Trends
- 3.1. Bioconjugation Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Bioconjugation Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Bioconjugation Market Opportunities
- 3.4. Bioconjugation Market Future Trends
4. Bioconjugation Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Bioconjugation Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Bioconjugation Market Landscape
- 6.1. Bioconjugation Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Bioconjugation Market - By Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
- 7.1.2. Natural Bioconjugates
- 7.1.3. Synthetic Bioconjugates
8. Bioconjugation Market - By Technique
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Technique, 2023 & 2032 (%)
- 8.1.2. Amide Bond Formation
- 8.1.3. Click Chemistry
- 8.1.4. Bio-orthogonal Reactions
- 8.1.5. Thiol-Maleimide Coupling
- 8.1.6. Enzymatic Methods
9. Bioconjugation Market - By Offering
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Offering, 2023 & 2032 (%)
- 9.1.2. Reagents & Kits
- 9.1.3. Services
- 9.1.3.1. ADC Process Development
- 9.1.3.2. Drug Substance Manufacturing
- 9.1.3.3. Analytical Development
- 9.1.3.4. Early Development Bioconjugate Services
- 9.1.3.5. Targeting Agent or Carrier Protein Services
- 9.1.3.6. Payload & Linker Manufacturing
10. Bioconjugation Market - By Bioconjugation Type
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Bioconjugation Type, 2023 & 2032 (%)
- 10.1.2. Oligonucleotide Bioconjugation
- 10.1.2.1. Single-stranded Oligonucleotides
- 10.1.2.2. Double-stranded Oligonucleotides
- 10.1.3. Polymer Bioconjugation
- 10.1.4. Peptide Bioconjugation
- 10.1.5. Protein Bioconjugation
11. Bioconjugation Market - By Application
- 11.1. Overview
- 11.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 11.1.2. Diagnostics
- 11.1.3. Therapeutic
- 11.1.3.1. Vaccines
- 11.1.3.2. Monoclonal Antibodies
- 11.1.3.3. Antibiotics
- 11.1.4. Research & Development
12. Bioconjugation Market - By Therapeutic Area
- 12.1. Overview
- 12.1.1. Segment Share Analysis, By Therapeutic Area, 2023 & 2032 (%)
- 12.1.2. Infectious Diseases
- 12.1.3. Immunology
- 12.1.4. Cardiovascular Disorders
- 12.1.5. Oncology
13. Bioconjugation Market - By End User
- 13.1. Overview
- 13.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
- 13.1.2. Biotechnology Companies
- 13.1.3. Academic & Research Institutions
- 13.1.4. Pharmaceutical Companies
- 13.1.5. Contract Research Organizations
14. Bioconjugation Market- By Geography
- 14.1. Introduction
- 14.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 14.2. North America
- 14.2.1. Overview
- 14.2.2. Bioconjugation Key Manufacturers in North America
- 14.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 14.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.2.5. North America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.2.6. North America Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.2.7. North America Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.2.9. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.2.10. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.2.11. U.S.
- 14.2.11.1. Overview
- 14.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.2.11.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.2.11.4. U.S. Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.2.11.5. U.S. Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.2.11.6. U.S. Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.2.11.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.2.11.8. U.S. Market Size and Forecast, By Bioconjugation Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.2.11.9. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.2.11.10.
- 14.2.12. Canada
- 14.2.12.1. Overview
- 14.2.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.2.12.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.2.12.4. Canada Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.2.12.5. Canada Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.2.12.6. Canada Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.2.12.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.2.12.8. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.2.12.9. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.2.12.10.
- 14.3. Europe
- 14.3.1. Overview
- 14.3.2. Bioconjugation Key Manufacturers in Europe
- 14.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 14.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.3.5. Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.3.6. Europe Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.3.7. Europe Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.3.9. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.3.10. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.3.11. Germany
- 14.3.11.1. Overview
- 14.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.3.11.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.3.11.4. Germany Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.3.11.5. Germany Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.3.11.6. Germany Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.3.11.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.3.11.8. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.3.11.9. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.3.12. Italy
- 14.3.12.1. Overview
- 14.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.3.12.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.3.12.4. Italy Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.3.12.5. Italy Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.3.12.6. Italy Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.3.12.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.3.12.8. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.3.12.9. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.3.13. United Kingdom
- 14.3.13.1. Overview
- 14.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.3.13.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.3.13.4. United Kingdom Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.3.13.5. United Kingdom Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.3.13.6. United Kingdom Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.3.13.7. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.3.13.8. United Kingdom Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.3.13.9. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.3.14. France
- 14.3.14.1. Overview
- 14.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.3.14.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.3.14.4. France Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.3.14.5. France Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.3.14.6. France Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.3.14.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.3.14.8. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.3.14.9. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.3.15. Russia
- 14.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.3.15.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.3.15.3. Russia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.3.15.4. Russia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.3.15.5. Russia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.3.15.7. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.3.15.8. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.3.16. Netherlands
- 14.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.3.16.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.3.16.3. Netherlands Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.3.16.4. Netherlands Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.3.16.5. Netherlands Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.3.16.6. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.3.16.7. Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.3.16.8. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.3.17. Sweden
- 14.3.17.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.3.17.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.3.17.3. Sweden Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.3.17.4. Sweden Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.3.17.5. Sweden Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.3.17.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.3.17.7. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.3.17.8. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.3.18. Poland
- 14.3.18.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.3.18.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.3.18.3. Poland Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.3.18.4. Poland Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.3.18.5. Poland Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.3.18.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.3.18.7. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.3.18.8. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.3.19. Rest of Europe
- 14.3.19.1. Overview
- 14.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.3.19.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.3.19.4. Rest of the Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.3.19.5. Rest of the Europe Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.3.19.6. Rest of the Europe Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.3.19.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.3.19.8. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.3.19.9. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.4. Asia Pacific (APAC)
- 14.4.1. Overview
- 14.4.2. Bioconjugation Key Manufacturers in Asia Pacific
- 14.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 14.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.4.5. Asia Pacific Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.4.6. Asia Pacific Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.4.7. Asia Pacific Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.4.8. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.4.9. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.4.10. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.4.11. India
- 14.4.11.1. Overview
- 14.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.4.11.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.4.11.4. India Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.4.11.5. India Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.4.11.6. India Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.4.11.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.4.11.8. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.4.11.9. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.4.12. China
- 14.4.12.1. Overview
- 14.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.4.12.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.4.12.4. China Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.4.12.5. China Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.4.12.6. China Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.4.12.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.4.12.8. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.4.12.9. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.4.13. Japan
- 14.4.13.1. Overview
- 14.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.4.13.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.4.13.4. Japan Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.4.13.5. Japan Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.4.13.6. Japan Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.4.13.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.4.13.8. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.4.13.9. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.4.14. South Korea
- 14.4.14.1. Overview
- 14.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.4.14.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.4.14.4. South Korea Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.4.14.5. South Korea Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.4.14.6. South Korea Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.4.14.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.4.14.8. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.4.14.9. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.4.15. Australia
- 14.4.15.1. Overview
- 14.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.4.15.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.4.15.4. Australia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.4.15.5. Australia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.4.15.6. Australia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.4.15.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.4.15.8. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.4.15.9. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.4.16. Thailand
- 14.4.16.1. Overview
- 14.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.4.16.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.4.16.4. Thailand Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.4.16.5. Thailand Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.4.16.6. Thailand Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.4.16.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.4.16.8. hailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.4.16.9. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.4.17. Indonesia
- 14.4.17.1. Overview
- 14.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.4.17.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.4.17.4. Indonesia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.4.17.5. Indonesia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.4.17.6. Indonesia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.4.17.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.4.17.8. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.4.17.9. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.4.18. Philippines
- 14.4.18.1. Overview
- 14.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.4.18.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.4.18.4. Philippines Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.4.18.5. Philippines Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.4.18.6. Philippines Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.4.18.7. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.4.18.8. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.4.18.9. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.4.19. Rest of APAC
- 14.4.19.1. Overview
- 14.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.4.19.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.4.19.4. Rest of APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.4.19.5. Rest of APAC Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.4.19.6. Rest of APAC Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.4.19.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.4.19.8. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.4.19.9. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.5. Latin America
- 14.5.1. Overview
- 14.5.2. Bioconjugation Key Manufacturers in Latin America
- 14.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 14.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.5.5. Latin America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.5.6. Latin America Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.5.7. Latin America Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.5.8. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.5.9. Latin America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.5.10. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.5.11. Brazil
- 14.5.11.1. Overview
- 14.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.5.11.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.5.11.4. Brazil Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.5.11.5. Brazil Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.5.11.6. Brazil Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.5.11.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.5.11.8. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.5.11.9. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.5.12. Mexico
- 14.5.12.1. Overview
- 14.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.5.12.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.5.12.4. Mexico Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.5.12.5. Mexico Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.5.12.6. Mexico Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.5.12.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.5.12.8. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.5.12.9. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.5.13. Argentina
- 14.5.13.1. Overview
- 14.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.5.13.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.5.13.4. Argentina Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.5.13.5. Argentina Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.5.13.6. Argentina Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.5.13.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.5.13.8. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.5.13.9. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.5.14. Colombia
- 14.5.14.1. Overview
- 14.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.5.14.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.5.14.4. Colombia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.5.14.5. Colombia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.5.14.6. Colombia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.5.14.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.5.14.8. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.5.14.9. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.5.15. Rest of LATAM
- 14.5.15.1. Overview
- 14.5.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.5.15.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.5.15.4. Rest of LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.5.15.5. Rest of LATAM Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.5.15.6. Rest of LATAM Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.5.15.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.5.15.8. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.5.15.9. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.6. Middle East and Africa
- 14.6.1. Overview
- 14.6.2. Bioconjugation Key Manufacturers in Middle East and Africa
- 14.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 14.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.6.5. Middle East and Africa Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.6.6. Middle East and Africa Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.6.7. Middle East and Africa Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.6.9. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.6.10. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.6.11. Saudi Arabia
- 14.6.11.1. Overview
- 14.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.6.11.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.6.11.4. Saudi Arabia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.6.11.5. Saudi Arabia Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.6.11.6. Saudi Arabia Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.6.11.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.6.11.8. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.6.11.9. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.6.12. United Arab Emirates
- 14.6.12.1. Overview
- 14.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.6.12.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.6.12.4. United Arab Emirates Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.6.12.5. United Arab Emirates Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.6.12.6. United Arab Emirates Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.6.12.7. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.6.12.8. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.6.12.9. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.6.13. Israel
- 14.6.13.1. Overview
- 14.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.6.13.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.6.13.4. Israel Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.6.13.5. Israel Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.6.13.6. Israel Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.6.13.7. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.6.13.8. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.6.13.9. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.6.14. Turkey
- 14.6.14.1. Overview
- 14.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.6.14.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.6.14.4. Turkey Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.6.14.5. Turkey Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.6.14.6. Turkey Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.6.14.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.6.14.8. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.6.14.9. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.6.15. Algeria
- 14.6.15.1. Overview
- 14.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.6.15.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.6.15.4. Algeria Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.6.15.5. Algeria Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.6.15.6. Algeria Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.6.15.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.6.15.8. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.6.15.9. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.6.16. Egypt
- 14.6.16.1. Overview
- 14.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.6.16.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.6.16.4. Egypt Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.6.16.5. Egypt Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.6.16.6. Egypt Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.6.16.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.6.16.8. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.6.16.9. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 14.6.17. Rest of MEA
- 14.6.17.1. Overview
- 14.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 14.6.17.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 14.6.17.4. Rest of MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
- 14.6.17.5. Rest of MEA Market Size and Forecast, By Offering, 2019 - 2032 (US$ Million)
- 14.6.17.6. Rest of MEA Market Size and Forecast, By Bioconjugation Type, 2019 - 2032 (US$ Million)
- 14.6.17.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 14.6.17.8. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 14.6.17.9. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
15. Key Vendor Analysis- Bioconjugation Industry
- 15.1. Competitive Dashboard
- 15.1.1. Competitive Benchmarking
- 15.1.2. Competitive Positioning
- 15.2. Company Profiles
- 15.2.1. AbbVie Inc.
- 15.2.2. Abcam plc
- 15.2.3. Abzena Limited
- 15.2.4. Agilent Technologies, Inc.
- 15.2.5. AstraZeneca PLC
- 15.2.6. Biocon Limited
- 15.2.7. Bio-Techne Corporation
- 15.2.8. Boehringer Ingelheim GmbH
- 15.2.9. Charles River Laboratories International, Inc.
- 15.2.10. Bristol-Myers Squibb Company
- 15.2.11. Eli Lilly and Company
- 15.2.12. GlaxoSmithKline plc
- 15.2.13. F. Hoffmann-La Roche AG
- 15.2.14. Innovagen AB
- 15.2.15. Lonza Group AG
- 15.2.16. Johnson & Johnson Services Inc.
- 15.2.17. Merck KGaA
- 15.2.18. Sanofi S.A.
- 15.2.19. Pfizer Inc.
- 15.2.20. Sartorius AG
- 15.2.21. Sutro Biopharma, Inc.
- 15.2.22. Sorrento Therapeutics, Inc.
- 15.2.23. Thermo Fisher Scientific Inc.
- 15.2.24. WuXi AppTec Co., Ltd.
- 15.2.25. Others
16. 360 Degree Analyst View
17. Appendix
- 17.1. Research Methodology
- 17.2. References
- 17.3. Abbreviations
- 17.4. Disclaimer
- 17.5. Contact Us
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.